» Articles » PMID: 32371508

Prevalence of Secondary Care Multimorbidity in Mid-life and Its Association with Premature Mortality in a Large Longitudinal Cohort Study

Overview
Journal BMJ Open
Specialty General Medicine
Date 2020 May 7
PMID 32371508
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Multimorbidity is the coexistence of two or more health conditions in an individual. Multimorbidity in younger adults is increasingly recognised as an important challenge. We assessed the prevalence of secondary care multimorbidity in mid-life and its association with premature mortality over 15 years of follow-up, in the Aberdeen Children of the 1950s (ACONF) cohort.

Method: A prospective cohort study using linked electronic health and mortality records. Scottish ACONF participants were linked to their Scottish Morbidity Record hospital episode data and mortality records. Multimorbidity was defined as two or more conditions and was assessed using healthcare records in 2001 when the participants were aged between 45 and 51 years. The association between multimorbidity and mortality over 15 years of follow-up (to ages 60-66 years) was assessed using Cox proportional hazards regression. There was also adjustment for key covariates: age, gender, social class at birth, intelligence at age 7, secondary school type, educational attainment, alcohol, smoking, body mass index and adult social class.

Results: Of 9625 participants (51% males), 3% had multimorbidity. The death rate per 1000 person-years was 28.4 (95% CI 23.2 to 34.8) in those with multimorbidity and 5.7 (95% CI 5.3 to 6.1) in those without. In relation to the reference group of those with no multimorbidity, those with multimorbidity had a mortality HR of 4.5 (95% CI 3.4 to 6.0) over 15 years and this association remained when fully adjusted for the covariates (HR 2.5 (95% CI 1.5 to 4.0)).

Conclusion: Multimorbidity prevalence was 3% in mid-life when measured using secondary care administrative data. Multimorbidity in mid-life was associated with premature mortality.

Citing Articles

Exploration of patients' and healthcare professionals' perspectives on kidney failure risk and the use of the kidney failure risk equation in MULTIPle lOng-term condItions aNd frailTy (MULTIPOINT) study: a qualitative interview and focus group study....

Walker H, Sullivan M, Jani B, Mark P, Gallacher K BMJ Open. 2024; 14(10):e085843.

PMID: 39424379 PMC: 11492959. DOI: 10.1136/bmjopen-2024-085843.


Current definitions of advanced multimorbidity: a protocol for a scoping review.

Bowers S, Black P, McCheyne L, Wilson D, Mills S, Agrawal U BMJ Open. 2023; 13(11):e076903.

PMID: 38035744 PMC: 10689385. DOI: 10.1136/bmjopen-2023-076903.


Multimorbidity in systemic lupus erythematosus in a population-based cohort: the Lupus Midwest Network.

Figueroa-Parra G, Meade-Aguilar J, Hulshizer C, Gunderson T, Chamberlain A, Thanarajasingam U Rheumatology (Oxford). 2023; 63(11):3056-3064.

PMID: 38001025 PMC: 11534092. DOI: 10.1093/rheumatology/kead617.


Patterns and Predictors of Multimorbidity in the Azar Cohort.

Somi M, Ostadrahimi A, Gilani N, Haji Kamanaj A, Hassannezhad S, Faramarzi E Arch Iran Med. 2023; 26(1):8-15.

PMID: 37543916 PMC: 10685807. DOI: 10.34172/aim.2023.02.


Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study.

Sorensen S, Frederiksen J, Anru P, Masud T, Petrovic M, Rosholm J Drugs Real World Outcomes. 2021; 9(1):129-140.

PMID: 34414558 PMC: 8844340. DOI: 10.1007/s40801-021-00270-7.


References
1.
Schram M, Frijters D, van de Lisdonk E, Ploemacher J, de Craen A, de Waal M . Setting and registry characteristics affect the prevalence and nature of multimorbidity in the elderly. J Clin Epidemiol. 2008; 61(11):1104-12. DOI: 10.1016/j.jclinepi.2007.11.021. View

2.
Johnston M, Black C, Mercer S, Prescott G, Crilly M . Impact of educational attainment on the association between social class at birth and multimorbidity in middle age in the Aberdeen Children of the 1950s cohort study. BMJ Open. 2019; 9(1):e024048. PMC: 6352766. DOI: 10.1136/bmjopen-2018-024048. View

3.
Hughes L, McMurdo M, Guthrie B . Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity. Age Ageing. 2012; 42(1):62-9. DOI: 10.1093/ageing/afs100. View

4.
Kone Pefoyo A, Bronskill S, Gruneir A, Calzavara A, Thavorn K, Petrosyan Y . The increasing burden and complexity of multimorbidity. BMC Public Health. 2015; 15:415. PMC: 4415224. DOI: 10.1186/s12889-015-1733-2. View

5.
Brewster D, Stockton D, Harvey J, Mackay M . Reliability of cancer registration data in Scotland, 1997. Eur J Cancer. 2002; 38(3):414-7. DOI: 10.1016/s0959-8049(01)00385-9. View